Aptahem AB (publ) (NGM:APTA)
Sweden · Delayed Price · Currency is SEK 0.8700
-0.0760 (-8.03%)
At close: Mar 18, 2026
Aptahem AB Market Cap
Aptahem AB has a market cap or net worth of 18.25 million as of March 19, 2026. Its market cap has increased by 84.76% in one year.
Market Cap
18.25M
Enterprise Value
15.28M
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.87
Market Cap Chart
Since April 17, 2015, Aptahem AB's market cap has decreased from 51.10M to 18.25M, a decrease of -64.29%. That is a compound annual growth rate of -8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 18.25M | -24.02% |
| Dec 30, 2025 | 24.01M | 35.28% |
| Dec 30, 2024 | 17.75M | -4.71% |
| Dec 29, 2023 | 18.63M | -73.52% |
| Dec 30, 2022 | 70.35M | -20.14% |
| Dec 30, 2021 | 88.10M | -5.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 61.80M |
| Pila Pharma AB | 50.43M |
| Nanologica AB | 36.67M |
| 2cureX AB | 33.01M |
| Modus Therapeutics Holding AB | 32.47M |
| Guard Therapeutics International AB | 31.36M |
| ExpreS2ion Biotech Holding AB | 17.93M |
| Fluicell AB | 15.11M |